Position in RPRX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$22,032,525
+$4,051,517 QoQ
Shares Held
459,298
-1.3% QoQ
Ownership
0.080%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 44%
Shared 0%
None 56%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,237,848,251 across 287 Biotechnology names. RPRX ranks #14 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in RPRX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $22,032,525 | 459,298 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $17,981,008 | 465,347 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $15,845,765 | 449,143 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $16,114,057 | 447,240 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $14,007,379 | 449,964 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $11,585,315 | 454,148 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $12,942,957 | 457,510 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $11,789,525 | 447,081 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $13,916,931 | 458,246 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $12,802,186 | 455,756 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $12,519,654 | 461,299 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $14,611,244 | 475,317 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $15,071,565 | 418,306 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $16,248,331 | 411,142 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $15,519,645 | 386,253 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $14,494,467 | 344,778 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $10,815,568 | 277,607 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $11,264,120 | 282,663 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $9,848,222 | 272,502 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $11,856,603 | 289,256 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $12,946,546 | 296,803 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $4,872,918 | 97,361 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $3,229,671 | 76,769 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||